Abnormal vaginal bleeding;Sângerarea uterinǎ anormalǎ

Gineco.ro

Volumn 5, Issue 3, 2009, Pages 184-191

  Bari, Maria ^a   Peçi, Elton Nikolla ^a   Panaitescu, Anca ^a  

^a Spitalul Clinic de Obstetric i Ginecologie Filantropia   (Romania)

Author keywords

Abnormal vaginal bleeding

Indexed keywords

SEX HORMONE;

ABNORMAL VAGINAL BLEEDING; HORMONE RESPONSE; METRORRHAGIA; PREGNANCY COMPLICATION; REVIEW; UTERUS BLEEDING; VAGINA BLEEDING;

EID: 79955796569     PISSN: 18414435     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Rees MC. Role of menstrual blood loss measurements in management of complaints of excessive menstrual bleeding. Br J Obstet Gynaecol 1991; 98: 327-8.
2. Warner P, Critchley HO, Lumsden MA, et al. Referral for menstrual problems: cross sectional survey of symptoms, reasons for referral, and management. BMJ 2001; 323 :24-8. (Pubitemid 32682003)
3. Wood C, Larsen L, Williams R, Menstrual characteristics of 2343 women attending the Shepherd Foundation, Aust N Z J Obstet Gynaecol 19: 107, 1979.
4. Vollman RF. The menstrual cycle. In: Friedman E, ed. Major problems in obstetrics and gynecology. Philadelphia, PA: WB Saunders, 1977: 1-193.
5. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality Acta Obstet Gynecol Scand 1966; 45: 320-51.
6. Munro MG. Abnormal uterine bleeding in the reproductive years. Part 1: pathogenesis and clinical investigations. J Am Assoc Gynecol Laparoscop 1999; 6: 391-428.
7. Hill NC, Oppenheimer LW, Morton KE. The aetiology of vaginal bleeding in children. A 20-year review. Br J Obstet Gynaecol 1989; 96: 467-70. (Pubitemid 19129149)
8. Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002; 8: 60-7. (Pubitemid 34144986)
9. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 6th ed. Baltimore: Lippincott Williams & Wilkins, 1999: 201-38,499,575-9.
10. Lethaby A, Farquhar C, Sarkis A, Roberts H, Jepson R, Barlow D. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 2003;(4):
11. Royal College of Obstetricians and Gynaecologists. The Initial Management of Menorrhagia. Evidence-Based Clinical Guidelines, 1.London: RCOG Press, 1998
12. Oheler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand 2003; 82: 405-22. (Pubitemid 36629848)
13. Higham JM, O'Brien PMS, Shaw RM, Assessment of menstrual blood loss using a pictorial chart, Br J Obstet Gynaecol 97: 734, 1990.
14. de Ziegler D, Bergeron C, Cornel C, et al. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab 1992; 74: 322331.
15. Belsey E. Vagnial bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 1988; 38: 181206.
16. Weingold AB. Abnormal bleeding. In: Kase NG, Weingold AB, Gershenson DM, eds. Principles and practice of clinical gynecology. New York: Churchill Livingstone, 1990.
17. Droegemuller W. Pediatric gynecology. In: Herbst AL, Mishell DR Jr, Stenchever MA, et al., eds. Comprehensive gynecology, 3rd ed. St. Louis: Mosby-Year Book, 1997.
18. Paradise JE, Willis ED. Probability of vaginal foreign body in girls with genital complaints. Am J Dis Child 1985; 139: 472-476.
19. Sanfflippo JS, Wakim NG. Bleeding and vulvovaginitis in the pediatric age group. Clin Obstet Gynecol 1987; 30: 653.
20. Speroff L, Glass RH, Kase Na. Dysfunctional uterine bleeding. In: Clinical Gynecologic Endocrinology and Fertility. Philadelphia: Lippincott Williams & Wilkins, 1999: 575-93
21. Clarke A, Black N, Rowe P, et al. Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study. Br J Obstet Gynaecol 1995; 102: 611-20.
22. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leio myomas: a review. Environ Health Perspect 2003; 111: 1037-54. (Pubitemid 36826884)
23. Hague S, Zhang L, Oehler MK, et al. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascu lar density. Clin Cancer Res 2000; 6: 2808-14. (Pubitemid 30482121)
24. Jha RC, Takahama J, Imaoka I, et al. Adenomyosis: MRI of the uterus treated with uterine artery embolization. AJR Am J Roentgenol 2003; 181: 851-6. (Pubitemid 37021866)
25. In: Novak ER, Woodruff JD, ed. Novak's Gynecologic and Obstetric Pathology with Clinical and Endocrine Relations, 8th ed. Philadelphia: WB Saunders; 1979.
26. Pettersson B, Adami HO, Lindgren A, et al: Endometrial polyps and hyperplasia as risk factors for endometrial carcinoma. Acta Obstet Gynecol Scand 1985; 64: 653.
27. Platz CE, Benda JA. Female genital tract cancer. Cancer 1995; 75: Suppl: 270-94.
28. Peterson EP. Endometrial carcinoma in young women: a clinical profile. Obstet Gynecol 1968; 31: 702-7.
29. Elwood JM, et al: Epidemiology of endometrial cancer. J Natl Cancer Inst 1977; 59: 1055-1060. (Pubitemid 8224268)
30. Kelsey JL, et al: A case-control study of cancer of the endometrium. Am J Epidemiol 1982; 116: 333-342. (Pubitemid 12048413)
31. Paavonen J, Kiviat N, Brunham RC, et al: Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol 1985; 152: 280.
32. Hadgu A, Weström L, Brooks CA, et al: Predicting acute pelvic inflammatory disease: A multivariate analysis. Am J Obstet Gynecol 155: 956, 1986.
33. Eckert LO, Hawes SE, Wølner-Hanssen PK, et al: Endometritis: The clinical-pathologic syndrome. Am J Obstet Gynecol 2002; 186(4): 690-695.
34. Lowenstein L, Solt I, Deutsch M, et al: A life-threatening event uterine cervical arteriovenous malformation. Obstet Gynecol 103: 1073, 2004.
35. Farrar HK, Nedoss BR: Benign tumors of the uterine cervix. Am J Obstet Gynecol 1961; 81: 124.
36. Rosenthal AN, Panoskaltsis T, Smith T, Soutter WP. The frequency of sig nificant pathology in women attending a general gynaecological service for postcoital bleeding. BJOG 2001; 108: 103-6. (Pubitemid 32102611)
37. Barber HRK. Incidence, prevalence, and median survival rates of gynecologic cancer. In: Van Nagell JR, Barber HRK, eds. Modern concepts of gynecologic oncology. Boston: John Wright-PSG, 1982: 1-19.
38. Lockwood C, Krikun G, Papp C et al. The role of progestionally regulated stromal cell tissue factor and type 1 plasminogen activator inhibitor (PAI 1) in endometrial hemostasis and menstruation. Ann NY Acad Sci 1994; 734: 57-9.
39. Kadir RA, Economides DL, Sabin CA, et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9. (Pubitemid 28070095)
40. Dilley A, Drews C, Miller C, et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia.Obstet Gynecol 2001; 97: 630-6.
41. Kouides PA. Menorrhagia from a haematologist's point of view. Part I: initial evaluation. Haemophilia 2002; 8:330-8.
42. Claessens EA, Cowell CA: Acute adolescent menorrhagia. Am J Obstet Gy necol 1981; 139:277-280. (Pubitemid 11191113)
43. Milsom I, Andersson K, Jonasson K, et al: The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status. Contraception 52:175, 1995.
44. Zhang JY, Luo LL: [Intrauterine device-induced menorrhagia and endometrial content of prostacyclins]. [Chinese]. Chung-Hua Fu Chan Ko Tsa Chih [Chinese J Obstet Gynecol] 27: 167, 1992.
45. Shaw ST Jr., Macaulay LK, Hohman WR: Vessel density in endometrium of women with and without intrauterine contraceptive devices: a morphometric evaluation. Am J Obstet Gynecol 135: 202, 1979.
46. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Use of botanicals for management of menopausal symptoms. Obstet Gynecol 2001; 96(6 suppl): 1-11.
47. Reynolds RF, Obermeyer CM, Walker AM, et al: The role of treatment intentions and concerns about side effects in women'sdecision to discontinue postmenopausal hormone therapy. Maturitas 43: 183, 2002.
48. Lethaby A, Suckling J, Bartow D, et al: Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding Cochrane Database Syst Rev DOI: 10.1002/14651858, 2004.
49. Wickerham DL, Constantino J, Fisher B, et al: The initial results from NSABP protocol P-1: a clinical trial to determine the worth of tamoxifen for preventing breast cancer in women at increased risk. Presented at the 34th Annual Meeting of the American Society of Clinical Oncology Plenary Session, Los Angeles, May 16-19, 1998.
50. Cohen I: Endometrial pathologies associated with postmenopausal tamoxifen treatment Gynecol Oncol 94: 256, 2004
51. van Eijkeren MA, Christiaens GC, Haspels AA, Sixma JJ. Measured menstru al blood loss in women with a bleeding disorder or usingoral anticoagulant therapy. Am J Obstet Gynecol 1990; 162: 1261-3. (Pubitemid 20174052)
52. Wein TH, Hickenbottom SL, Morgenstern LB, et al. Safety of tissue plasminogen activator for acute stroke in menstruating women.Stroke 2002; 33: 2506-8.
53. Koch AZ, Abubaker J, Barnett VT, Chan LN. Use of thrombo lytic therapy to treat heparinrefractory pulmonary embolism in a menstruating patient. Pharmacotherapy 2002; 22: 118-22. (Pubitemid 34042398)
54. Krassas GE, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf) 1999; 50: 655-9.
55. Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000;74:1063-70.
56. Hickey M, Fraser IS: Clinical implications of disturbances of uterine vascular morphology and function. Baillieres Best Pract Res Clin Obstet Gynaecol 14: 937, 2000.
57. March CM. Dysfunctional uterine bleeding. In: Mishell DR Jr, Davajan V, Lobo RA, eds. Infertility, Contraception and Reproductive Endocrinology. Boston: Blackwell Scientific Publ. 1991: 488.
58. Kurman RJ, Mazur MT. Benign diseases of the endometrium. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. NewYork: Springer-Verlag 1987: 292.
59. Lobo RA. The syndrome of Hyperandrogenic Chronic Anovulation. In: Mishell DR Jr, Davajan V, Lobo RA, eds. Infertility, Contraception and Reproductive Endocrinology. Boston: Blackwell Scientific Publ. 1991:447.
60. Wilansky D, Greisman B. Early hypothyroidism in patients with menorrhagia. Am J Obstet Gynecol 1989; 160.
61. Makarainen L, Ylikorkala O. Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen. Br J ObstetGynaecol 1986; 93: 974-8. (Pubitemid 16029531)
62. Rees MC, Anderson AB, Demers LM, Turnbull AC. Prostaglan dins in menstrual fluid in menorrhagia and dysmenorrhoea. Br J ObstetGynaecol 1984; 91: 673-80. (Pubitemid 14086880)
63. Adelantado JM, Rees MC, Lopez Bernal A, Turnbull AC. Increased uterine prostaglandin E receptors in menorrhagic women. Br J Obstet Gynaecol 1988; 95: 162-5.
64. Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prosta glandins in pathology of the endometrium. Reproduction 2003; 126: 559-67. (Pubitemid 37540615)
65. Zervou S, Klentzeris LD, Old RW. Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia.Mol Hum Reprod 1999; 5: 1048-54.
66. Gleeson NC. Cyclic changes in endometrial tissue plasmino gen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrha gia. Am J Obstet Gynecol 1994; 171: 178-83. (Pubitemid 24254438)
67. Vincent AJ, Zhang J, Ostor A, et al. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloprotein ase balance in the pathogenesis of abnormal uterine bleeding? Hum Reprod 2002; 17: 1189-98. (Pubitemid 34537348)
68. Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003; 24: 428-65. (Pubitemid 37056240)
69. Cornet PB, Picquet C, Lemoine P, et al. Regulation and func tion of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progester one, and effect on matrix metalloproteinases. J Biol Chem 2002; 277: 42496-504. (Pubitemid 35285616)